Bloomsbury Publishing Plc (BMY)
London Stock Exchange · UK · prices in GBX · close of 27 Oct 2026
Key indicators
| Last close | GBX 648.00 |
|---|---|
| 52-week range | 435.00 – 695.00 |
| Return, 1 month / 3 months | +4.5% / +5.2% |
| Return, 1 year / 3 years | +29.6% / +66.3% |
| Trend | Uptrend |
| RSI (14) | 49 |
| Volatility (1 year) | 30.3% |
| Worst drawdown (1 year) | -16.8% |
| Average daily value traded | 206.56M GBX |
| Dividend yield | 2.5% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Bloomsbury Publishing is an independent book publisher based in London. It publishes fiction and non-fiction for general readers, including novels and children's books, and it also produces academic, educational and professional titles through its specialist imprints. Its authors and titles reach readers through bookshops, online retailers and libraries in many countries, and the company also licenses rights to publishers and media producers abroad.
On this site Bloomsbury Publishing Plc appears as a stock on the London Stock Exchange (UK), code BMY, with prices in pence sterling (GBX). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Bloomsbury Publishing Plc (BMY) trades on the London Stock Exchange in UK. It last closed at GBX 648.00 on 27 October 2026.
Its price-based Market X-Ray is 73 out of 100 (a strong price profile), ranking 347 of 3,788 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 29.6% and over the last three months it rose 5.2%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 75 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 8.8% | ||
| From 52-week high | -5.7% | ||
| Momentum | 65 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 5.2% | ||
| 6-month return | 3.4% | ||
| 12-month return, skipping the last month | 24.0% | ||
| Stability (higher is calmer) | 72 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 30.3% | ||
| Worst drawdown, 1 year (smaller is calmer) | -16.8% | ||
| Liquidity | 92 · Strong | Trades actively. | |
| Average daily value traded | 206.56M GBX | ||
| Zero-volume days | 0.0% | ||
| Income | 64 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 2.5% | ||
| Years with dividends | 6 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
- Liquidity: Trades actively.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | −5.1% |
|---|---|
| 1 month | +4.5% |
| 3 months | +5.2% |
| 6 months | +3.4% |
| 1 year | +29.6% |
| 3 years | +66.3% |
| 5 years | +76.8% |
Signals
| 50-day / 200-day average | 640.56 / 595.35 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 21.05 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 23 Jul 2026 | GBP 0.1212 |
| 30 Oct 2025 | GBP 0.0408 |
| 24 Jul 2025 | GBP 0.1154 |
| 31 Oct 2024 | GBP 0.0389 |
| 25 Jul 2024 | GBP 0.1099 |
| 2 Nov 2023 | GBP 0.0370 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.